OmniaBio
United States
Member Since:Mar 05, 2024
Ownership:N/A
Number of Offices:N/A
Total Employees:51-200
Established In:2022
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.
No record available!
No record available!
No record available!
No record available!
No record available!
No record available!